How I Coped with 40 Rejections – Farzana Rahman, CEO, Hexarad

Why It Matters

Hexarad’s AI‑driven solution could significantly cut imaging wait times, easing pressure on the NHS and setting a benchmark for digital health innovation. Its success demonstrates investor confidence in scaling health‑tech startups addressing systemic care gaps.

Key Takeaways

• Founder endured 40 rejections before securing funding
• Hexarad offers AI‑driven radiology diagnoses
• Platform addresses NHS imaging backlog
• AI reduces turnaround time for MRI reports
• HSBC Innovation Banking backs health‑tech startups

Pulse Analysis

The National Health Service faces mounting pressure from rising imaging referrals, leading to prolonged wait times for CT and MRI results. Amid this strain, AI‑enhanced radiology platforms are emerging as a pragmatic solution, offering faster interpretation without compromising diagnostic accuracy. Farzana Rahman’s transition from frontline doctor to tech founder underscores a broader trend: clinicians leveraging domain expertise to build digital tools that directly address systemic bottlenecks.

Hexarad’s platform integrates deep‑learning algorithms with a cloud‑based workflow, allowing radiologists to upload scans and receive AI‑augmented preliminary reads within minutes. This accelerates triage, reduces radiologist burnout, and frees up specialist time for complex cases. The company’s recent financing round, led by HSBC Innovation Banking, provides the capital needed to expand its UK footprint and refine its proprietary models, positioning Hexarad as a competitive player in a market projected to exceed $5 billion by 2028.

Beyond immediate operational gains, Hexarad’s trajectory signals a shift in health‑tech investment dynamics. Traditional venture capital is increasingly partnering with specialist banking arms to de‑risk early‑stage health ventures, recognizing the long‑term value of AI in public‑health infrastructure. As more hospitals adopt such platforms, the ripple effect could reshape diagnostic pathways, improve patient outcomes, and set new standards for data‑driven care across Europe.